because nobody’s ready for today yet
Ever wonder what Thanksgiving dinner is like in the Obama Administration? Do they simply agree never to talk about cannabis reform, the way my family has learned to avoid talking about football in Washington, D.C.? A week after Loretta Lynch said she disagreed with the President’s views on legalization, U.S. Surgeon General Vivek Murthy, in an interview with “CBS This Morning,” stated: “we have some preliminary data showing that for certain medical conditions and symptoms, marijuana can be helpful.” Murthy went on to say that he wants the country’s cannabis policy to be defined by research and data and is “very interested to see where that data takes us.” Like perhaps to a reclassification of marijuana’s Schedule I Controlled Substance status? Tom Angell of Marijuana Majority sure thinks so, and he hopes the President presses for action. Read the story and watch the interview here:
Just a week after declaring that no medical marijuana licenses would be issued in Illinois any time soon, new Republican Governor Bruce Rauner granted over 50 permits related to the plant’s cultivation and sale. The move was clearly a surprise, and no explanation was given for the sudden change in policy. There was talk of political shenanigans under the previous administration, and the quick reversal hasn’t made people feel much better, especially those who didn’t get a license. The Chicago Tribune has more details:
Leading the world in cannabis research for over 50 years, Israel is now considering options for disseminating not only its research, but also its products, abroad. Although many within the executive branch, police force, and army worry that they could “be seen…as a country that exports weapons and cannabis,” Michael Dor, the senior medical advisor in the Israeli Health Ministry’s cannabis unit warns that waiting too long could damage their position of prominence: “Israel is at the forefront of medical marijuana…why would Israel want to forgo its leadership?” The link to the article is below. It’s a great introduction to the history of cannabis research and to the fact if you truly wanted to study the medical benefits of the plant, you had to go outside the United States.
Safe access to medicine should be at the forefront of all cannabis conversations; nothing should supersede that. Then, only after suffering patients get the relief they need, we feel it’s time to tackle another important issue: if it’s possible to grow cannabis that doesn’t get you high but retains all the amazing medical benefits, is the reverse also achievable? Can they make a strain that has no medical benefits but gets you high as shit? Or do such mood-enhancing effects count as a medical benefit? We eagerly await word from Israel.